ENDRA Life Sciences Inc. (NDRA) Capital expenditures 2017–2025
ENDRA Life Sciences Inc. (NDRA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$17,280FY2025 · since FY2017: $7,862 → $17,280
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $17,280 | +8.0% |
| FY2024 | $16,000 | -52.8% |
| FY2023 | $33,884 | -83.3% |
| FY2022 | $202,577 | +350.2% |
| FY2021 | $45,000 | -40.3% |
| FY2020 | $75,333 | +72.8% |
| FY2019 | $43,595 | -56.4% |
| FY2018 | $100,000 | +1171.9% |
| FY2017 | $7,862 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice